Prof. Dr. Christoph W. Michalski

Weitere Beteiligungen

• Do, 15.02.

  16:05 – 16:10 3 Min. 2 Min.

  • ePoster presentation
  • P13

  ChatGPT vs. surgeons on pancreatic cancer queries: Accuracy & empathy evaluated by patients and experts

   AI and decicion making in pancreatology
• Do, 15.02.

  17:30 – 17:40 8 Min. 2 Min.

  • Oral presentation
  • O13

  Integrin-mediated tumor-stroma interfacial signaling promotes basal-like and immune exclusion phenotype in pancreatic ductal adenocarcinoma

   Pancreatic cancer
• Fr, 16.02.

  15:45 – 15:55 8 Min. 2 Min.

  • Oral presentation
  • O29

  A response prediction platform for personalized antitumor therapy in pancreatic cancer

   Pancreatic cancer
• Fr, 16.02.

  16:15 – 16:25 8 Min. 2 Min.

  • Oral presentation
  • O32

  Tumor response grading as a potential prognostic marker in neoadjuvant treated pancreatic carcinoma

   Pancreatic cancer
• Sa, 17.02.

  11:25 – 11:30 3 Min. 2 Min.

  • ePoster presentation
  • P81

  Objective research priorities in pancreatic surgery – Results of a worldwide online expert survey

   Pancreatic surgery / Robotics
• Sa, 17.02.

  11:30 – 11:35 3 Min. 2 Min.

  • ePoster presentation
  • P71

  Cell of origin influences transcriptional phenotype of pancreatic ductal adenocarcinoma

   Pancreatic cancer
• Sa, 17.02.

  11:35 – 11:40 3 Min. 2 Min.

  • ePoster presentation
  • P72

  Defining the adipose immune environment in PDAC associated cachexia and pre-cachexia

   Pancreatic cancer
• Sa, 17.02.

  13:00 – 13:10 8 Min. 2 Min.

  • Oral presentation
  • O56

  Irf3 and Irf7 are crucial factors for controlling a tumor-promoting epigenetic program

   Pancreatic cancer